From the folks who brought you Viagra – a vaccine

Outsider Pfizer covid-19 vaccine

13 November 2020
| By Outsider |
image
image
expand image

Outsider regrets to say that his extensive portfolio of investments does not include pharmaceutical giant Pfizer which at the time of writing has announced that with its German partner, BioNTech has come up with a COVID-19 vaccine which appears to be 90% effective.

Outsider’s regret is that he was not able to surf the 15% surge in in Pfizer’s share price generated by the vaccine announcement because, as everyone knows, it is handy if you can sell down a few shares during a spike.

For the record, this is not the first time that Outsider has missed the boat on a Pfizer breakthrough. The last time was in 1989 when he somehow failed to notice that the pharmaceutical giant had somehow managed, by accident, to invent Viagra.

Now, if Pfizer is on the money with this COVID-19 vaccine then it will be distributed to millions around the globe, which will be similar to the distribution of Viagra which apparently generated the writing of more than two million prescriptions in the US last year albeit the outcomes will be distinctly different.

From what Outsider is told, the COVID-19 vaccine will drive temperatures down while, from what he hears, Viagra tends to drive temperatures up.

Either way, Pfizer investors can stand tall, having found themselves in a happily solid position.

Read more about:

AUTHOR

Recommended for you

sub-bgsidebar subscription

Never miss the latest news and developments in wealth management industry

MARKET INSIGHTS

Completely agree Peter. The definition of 'significant change is circumstances relevant to the scope of the advice' is s...

3 weeks 4 days ago

This verdict highlights something deeply wrong and rotten at the heart of the FSCP. We are witnessing a heavy-handed, op...

1 month ago

Interesting. Would be good to know the details of the StrategyOne deal....

1 month ago

Insignia Financial has confirmed it is considering a preliminary non-binding proposal received from a US private equity giant to acquire the firm. ...

1 week 3 days ago

Six of the seven listed financial advice licensees have reported positive share price growth in 2024, with AMP and Insignia successfully reversing earlier losses. ...

5 days 15 hours ago

Specialist wealth platform provider Mason Stevens has become the latest target of an acquisition as it enters a binding agreement with a leading Sydney-based private equi...

4 days 19 hours ago